Definitely, future studies are required to determine whether these different assignments of VHL gene losses in G1 and G3 ccRCC tumours were due to technical differences in scoring DNA losses or scientifically explainable by accompanied duplication of the remaining chromosomal region eventually resulting in copy-neutral loss of heterozygosity (LOH). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.